Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Fibrin Clot Shields Formation in the Tumor Microenvironment, Induced By Cancer Cells' Hypercoagubility, Serves As Scaffolds for Invasion and Protection Against Anticancer Treatments

Chi Mai Huong Tran, Patrick Van Dreden, Elisabeth Mbemba, Aurelie Rousseau, Eleftheria Lefkou, Michele Sabbah, Grigoris Gerotziafas

Blood (2024) 144 (Supplement 1): 5528.

https://doi.org/10.1182/blood-2024-199040

Published: 2024

Journal Articles

Circulating Derived Tissue Factor Positive Microparticles and Thrombin Generation a Promising Tool for Identifying Cases at Increased Risk of Thrombotic Complications

Patrick Van Dreden, Aurelie Rousseau, Matthieu Grusse, Grigoris Gerotziafas

Blood (2024) 144 (Supplement 1): 3889.

https://doi.org/10.1182/blood-2024-199030

Published: 2024

Journal Articles

Evaluation of Clinical Risk Factors and Thrombosis-Related Biomarkers in Newly Diagnosed Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. the Observational Roadmat-CAT-MM Study

Patrick Van Dreden, Loula Papageorgiou, Eleftheria Lefkou, Despina Fotiou, Efstathios Kastritis, Evangelos Terpos, Aurelie Rousseau, Michele Sabbah, Matthieu Grusse, Ismail Elalamy, Elisabeth Mbemba, Meletios Athanasios Dimopoulos, Grigoris Gerotziafas

Blood (2023) 142 (Supplement 1): 5404.

https://doi.org/10.1182/blood-2023-187055

Published: 2023

Journal Articles

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Patrick Van Dreden, Eleftheria Lefkou, Aurelie Rousseau, Kostas Sfakianoudis, Grigoris Gerotziafas

Blood (2023) 142 (Supplement 1): 5406.

https://doi.org/10.1182/blood-2023-188792

Published: 2023

Journal Articles

Prothrombotic Profile in Patients with Active Multiple Myeloma and the Impact of Immunomodulators: The Roadmap-MM Study

Patrick Van Dreden, Loula Papageorgiou, Eleftheria Lefkou, Despina Fotiou, Efstathios Kastritis, Evangelos Terpos, Aurelie Rousseau, Michele Sabbah, Matthieu Grusse, Elisabeth Mbemba, Ismail Elalamy, Meletios Athanasios Dimopoulos, Grigoris Gerotziafas

Blood (2023) 142 (Supplement 1): 1203.

https://doi.org/10.1182/blood-2023-186645

Published: 2023

Journal Articles

Leukemia Inhibitory Factor, Tissue Factor, Thrombomodulin, P-Selectine, D-Dimer, Thrombin Generation and Procoagulant Phospholipid Dependent Clotting Time Are Predictive for in Vitro Fertilization Outcome. the Prospective Roadmap-IVF Study

Eleftheria Lefkou, Panagiotis Tzonis, Kostas Sfakianoudis, Aurelie Rousseau, Ismail Elalamy, Matthieu Grusse, Elisabeth Mbemba, Patrick Van Dreden, Grigoris Gerotziafas

Blood (2023) 142 (Supplement 1): 5413.

https://doi.org/10.1182/blood-2023-186236

Published: 2023

Journal Articles

Sex Hormone Levels, Biomarkers of Hypercoagulability and Endothelial Cell Activation Are Determinants of Severity of COVID-19 in Women and Men. the Roadmap-COVID-19 Prospective Study

Patrick Van Dreden, Salahdin Khelifi Otmane, Grigorios T. Gerotziafas, Matthieu Grusse, Aurélie Rousseau, Lila Louadj, Michele Sabbah

Blood (2022) 140 (Supplement 1): 5649–5650.

https://doi.org/10.1182/blood-2022-168576

Published: 2022

Journal Articles

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Patrick Van Dreden, Douglas D Fraser, Guillaume Voiriot, Aurélie Rousseau, Ismail Elalamy, Ioannis Prassas, Evangelos Terpos, Meletios A. Dimopoulos, Matthieu Grusse, Grigoris Gerotziafas

Blood (2021) 138 (Supplement 1): 2121.

https://doi.org/10.1182/blood-2021-146483

Published: 2021

Journal Articles

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study

Patrick Van Dreden, Joseph Gligorov, Evangelos Terpos, Mathieu Jamelot, Michele Sabbah, Despina Fotiou, Aboubakr Ka, Joanna Charitaki, Ismail Elalamy, Tina Bagratuni, Jawed Fareed, Aurélie Rousseau, Meletios A. Dimopoulos, Grigoris Gerotziafas

Blood (2021) 138 (Supplement 1): 3207.

https://doi.org/10.1182/blood-2021-146803

Published: 2021

Journal Articles

Differences in the Coagulation Profile in Women with Mild and Severe Preeclampsia

Elmina Lefkou, Patrick Van Dreden, PhD, Aurélie Rousseau, PhD, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-137401

Published: 2020

Journal Articles

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Patrick Van Dreden, PhD, Guillaume Voiriot, Alexandre Alabbadi, Ismail Elalamy, MD PhD, Loula Papageorgiou, Hélène Cost, Aurélie Rousseau, PhD, Matthieu Turpin, Muriel Fartoukh, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140275

Published: 2020

Journal Articles

Profile of Thrombin Generation Assay and Thromboelastometry in Women with Moderate and Severe Preeclampsia. the Roadmap-Preeclampsia Study

Patrick Van Dreden, PhD, Elmina Lefkou, Aurélie Rousseau, PhD, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-137384

Published: 2020

Journal Articles

Transmission of Procoagulant Properties to Daughter Generations of Endothelial Cells upon Exposure to Cancer Cell-Derived Microparticles. a New Implication of Cancer Derived Microparticles in the Pathogenesis of Cancer Associated Thrombosis

Rania Amrane, Aurélie Rousseau, PhD, Annette Larsen, Patrick Van Dreden, PhD, Grigorios T. Gerotziafas

Blood (2018) 132 (Supplement 1): 1231.

https://doi.org/10.1182/blood-2018-99-114685

Published: 2018

Journal Articles

Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis

Aurélie Rousseau, PhD, Rania Amrane, Patrick Van Dreden, PhD, Loula Papageorgiou, Annette Larsen, Amir Khaterchi, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 3698.

https://doi.org/10.1182/blood.V130.Suppl_1.3698.3698

Published: 2017

Journal Articles

Acquision of Resistance to Doxorubicin By Breast Cancer Cells MCF7 Enhances Their Procoagulant Properties and Alters the Efficacy of Antithrombotic Agents to Inhibit Thrombin Generation

Aurélie Rousseau, Patrick Van Dreden, PhD, Amir Khaterchi, Elisabeth Mbemba, Annette Larsen, Ismail Elalamy, MDPhD, Grigorios T. Gerotziafas, Dr

Blood (2015) 126 (23): 1113.

https://doi.org/10.1182/blood.V126.23.1113.1113

Published: 2015

Journal Articles

Newly Diagnosed Multiple Myeloma Is Associated with Enhanced TF Pathway Activation, Thrombin Generation and Increased Concentration of Procoagulant Microparticles

Grigorios T. Gerotziafas, Dr, Flora Zagouri, Despina Fotiou, Theodoros N. Sergentanis, Kimon Stamatelopoulos, Theodora Psaltopoulou, Efstathios Kastritis, MD, Evangelos Terpos, MD, Patrick Van Dreden, PhD, Aurélie Rousseau, Ilias Evmorfiadis, Ismail Elalamy, MDPhD, Annette Larsen, Meletios A. Dimopoulos

Blood (2015) 126 (23): 1074.

https://doi.org/10.1182/blood.V126.23.1074.1074

Published: 2015

Journal Articles

Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. the Roadmap Study

Ilias Evmorfiadis, Paraskevi Boura, Aurélie Rousseau, Ariadni Charpidou, Giannis Giozos, Patrick Van Dreden, PhD, Konstantinos Syrigos, Anastasia Spanoudaki, Matthieu Grusse, Ismail Elalamy, MD, Grigorios T. Gerotziafas, Dr

Blood (2014) 124 (21): 4253.

https://doi.org/10.1182/blood.V124.21.4253.4253

Published: 2014

Journal Articles

Use of Thrombin Generation Assay As Tool for the Evaluation of the Antithrombotic Samenesse of Enoxaparine Copies

Grigorios T. Gerotziafas, Dr, Patrick Van Dreden, PhD, Aurélie Rousseau, Amir Khaterchi, Jeanine M. Walenga, PhD, Jawed Fareed, PhD, Ismail Elalamy, MD

Blood (2014) 124 (21): 5092.

https://doi.org/10.1182/blood.V124.21.5092.5092

Published: 2014

Journal Articles

Distinct Roles Of Antithrombin-Dependent Antithrombotic Agents (Lovenox, Fondaparinux) and Direct Anti-Xa Anti-Coagulant (Apixaban) On The Inhibition Of Thrombin Generation Induced By Human Pancreatic (BXPC3) and Human Breast (MCF7) Cells

Aurélie Rousseau, Patrick Van Dreden, Ph.D., Elisabeth Mbemba, Mohamed Hatmi, Amir Kharterchi, Marie-Paule Roman, Ismail Elalamy, MD, Grigoris T Gerotziafas

Blood (2013) 122 (21): 3632.

https://doi.org/10.1182/blood.V122.21.3632.3632

Published: 2013

Journal Articles

Impact Of Thrombin Generation, Tissue Factor Activity and Thrombomodulin Activity On The Positivity Of Assisted Reproductive Technique In Infertile Women

Emmanuelle Mathieu d'Argent, Patrick Van Dreden, Ph.D., Marjorie Comtet, Vassiliki Galea, Hela Ketatni, Matthieu Grusse, Jean-Marie Antoine, Severine Bouffard, Aurélie Rousseau, Elmina Lefkou, Ismail Elalamy, MD, Grigoris T Gerotziafas

Blood (2013) 122 (21): 3630.

https://doi.org/10.1182/blood.V122.21.3630.3630

Published: 2013

NARROW

Fibrin Clot Shields Formation in the Tumor Microenvironment, Induced By Cancer Cells' Hypercoagubility, Serves As Scaffolds for Invasion and Protection Against Anticancer Treatments

Circulating Derived Tissue Factor Positive Microparticles and Thrombin Generation a Promising Tool for Identifying Cases at Increased Risk of Thrombotic Complications

Evaluation of Clinical Risk Factors and Thrombosis-Related Biomarkers in Newly Diagnosed Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. the Observational Roadmat-CAT-MM Study

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Prothrombotic Profile in Patients with Active Multiple Myeloma and the Impact of Immunomodulators: The Roadmap-MM Study

Leukemia Inhibitory Factor, Tissue Factor, Thrombomodulin, P-Selectine, D-Dimer, Thrombin Generation and Procoagulant Phospholipid Dependent Clotting Time Are Predictive for in Vitro Fertilization Outcome. the Prospective Roadmap-IVF Study

Sex Hormone Levels, Biomarkers of Hypercoagulability and Endothelial Cell Activation Are Determinants of Severity of COVID-19 in Women and Men. the Roadmap-COVID-19 Prospective Study

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study

Differences in the Coagulation Profile in Women with Mild and Severe Preeclampsia

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Profile of Thrombin Generation Assay and Thromboelastometry in Women with Moderate and Severe Preeclampsia. the Roadmap-Preeclampsia Study

Transmission of Procoagulant Properties to Daughter Generations of Endothelial Cells upon Exposure to Cancer Cell-Derived Microparticles. a New Implication of Cancer Derived Microparticles in the Pathogenesis of Cancer Associated Thrombosis

Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis

Acquision of Resistance to Doxorubicin By Breast Cancer Cells MCF7 Enhances Their Procoagulant Properties and Alters the Efficacy of Antithrombotic Agents to Inhibit Thrombin Generation

Newly Diagnosed Multiple Myeloma Is Associated with Enhanced TF Pathway Activation, Thrombin Generation and Increased Concentration of Procoagulant Microparticles

Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. the Roadmap Study

Use of Thrombin Generation Assay As Tool for the Evaluation of the Antithrombotic Samenesse of Enoxaparine Copies

Distinct Roles Of Antithrombin-Dependent Antithrombotic Agents (Lovenox, Fondaparinux) and Direct Anti-Xa Anti-Coagulant (Apixaban) On The Inhibition Of Thrombin Generation Induced By Human Pancreatic (BXPC3) and Human Breast (MCF7) Cells

Impact Of Thrombin Generation, Tissue Factor Activity and Thrombomodulin Activity On The Positivity Of Assisted Reproductive Technique In Infertile Women

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only